Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes

OBJECTIVE: Diabetes has emerged as an important risk factor for mortality from COVID-19. Metformin, the most commonly prescribed glucose-lowering agent, has been proposed to influence susceptibility to and outcomes of COVID-19 via multiple mechanisms. We investigated whether, in patients with diabet...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jingya, Cooper, Jennifer M, Gokhale, Krishna, Acosta-Mena, Dionisio, Dhalla, Samir, Byne, Nathan, Chandan, Joht Singh, Anand, Astha, Okoth, Kelvin, Subramanian, Anuradhaa, Bangash, Mansoor N, Jackson, Thomas, Zemedikun, Dawit, Taverner, Tom, Hanif, Wasim, Ghosh, Sandip, Narendran, Parth, Toulis, Konstantinos A, Tahrani, Abd A, Surenthirakumaran, Rajendra, Adderley, Nicola J, Haroon, Shamil, Khunti, Kamlesh, Sainsbury, Christopher, Thomas, G Neil, Nirantharakumar, Krishnarajah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928949/
https://www.ncbi.nlm.nih.gov/pubmed/33560344
http://dx.doi.org/10.1210/clinem/dgab067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928949/
https://www.ncbi.nlm.nih.gov/pubmed/33560344
http://dx.doi.org/10.1210/clinem/dgab067

Ejemplares similares